Depressive disorders are one of the most Depressive disorders are one of the most important mental health problems worldimportant mental health problems worldwide (Lepine, 2001) . Over the past decades, wide (Lepine, 2001) . Over the past decades, effective biological and psychological effective biological and psychological treatments have been developed, and treatments have been developed, and various treatment guidelines have been various treatment guidelines have been compiled to improve the quality of treatcompiled to improve the quality of treatment (American Psychiatric Association, ment (American Psychiatric Association, 2000; Deutsche Gesellschaft fur Psychiatrie, 2000; Deutsche Gesellschaft fü r Psychiatrie, Psychotherapie und Nervenheilkunde, 2000) . Psychotherapie und Nervenheilkunde, 2000) . Adherence to guidelines has been shown to Adherence to guidelines has been shown to enhance treatment outcome (Melfi enhance treatment outcome (Melfi et al et al, , 1998) but is still variable in clinical practice 1998) but is still variable in clinical practice (Ackerman (Ackerman et al et al, 2002; Harter , 2002; Hä rter et al et al, 2004; , 2004; Schneider Schneider et al et al, 2004) . The aim of this , 2004). The aim of this study is to describe the status of treatment study is to describe the status of treatment of in-patients for depression in Germany of in-patients for depression in Germany and to compare treatment routines with and to compare treatment routines with guideline recommendations in order to guideline recommendations in order to identify starting points for quality manageidentify starting points for quality management. Owing to increasing medical costs ment. Owing to increasing medical costs and tight budgets, there is a growing need and tight budgets, there is a growing need for quality management to assure effective for quality management to assure effective and high standards of care. and high standards of care.
METHOD METHOD Design Design
This was conducted as a multicentre study. This was conducted as a multicentre study. For each patient, data were collected at For each patient, data were collected at admission, during in-patient treatment and admission, during in-patient treatment and at discharge. Within the first 3 days of at discharge. Within the first 3 days of admission patients were asked to rate their admission patients were asked to rate their level of depression. The psychiatrists doculevel of depression. The psychiatrists documented the patients' socio-demographic mented the patients' socio-demographic characteristics, history of depression and characteristics, history of depression and psychopathology, and rated the patients' psychopathology, and rated the patients' levels of depression. During in-patient levels of depression. During in-patient treatment they noted treatment chartreatment they noted treatment characteristics (e.g. diagnostic and therapeutic acteristics (e.g. diagnostic and therapeutic procedures) as well as psychopathology procedures) as well as psychopathology (Psychiatric Basic Documentation System (Psychiatric Basic Documentation System, , BADO; Cording BADO; Cording et al et al, 1995) on a weekly , 1995) on a weekly basis. At discharge the patients rated their basis. At discharge the patients rated their level of depression and satisfaction with level of depression and satisfaction with treatment. The psychiatrists rated the treatment. The psychiatrists rated the patients' level of depression and noted patients' level of depression and noted other variables (e.g. subsequent treatment, other variables (e.g. subsequent treatment, changes in job situation). changes in job situation).
Assessment tools Assessment tools
In order to take into account the comIn order to take into account the complexity of treatment for depression, we plexity of treatment for depression, we assessed structure, process and outcome assessed structure, process and outcome quality aspects (Donabedian, 1966; Fig. 1) . quality aspects (Donabedian, 1966; Fig. 1) . For assessing psychopathology, we chose For assessing psychopathology, we chose the self-rating Beck Depression Inventory the self-rating Beck Depression Inventory (BDI; Beck (BDI; Beck et al et al, 1961) , the expert-rating , 1961), the expert-rating Hamilton Rating Scale for Hamilton Rating Scale for Depression Depression (HRSD, 21-item version; Hamilton, 1967) (HRSD, 21-item version; Hamilton, 1967) and the Global Assessment and the Global Assessment of Functioning of Functioning Scale (GAF; American Scale (GAF; American Psychiatric AssociaPsychiatric Association, 1994). The ZUF-8 tion, 1994) . The ZUF-8 (Schmidt (Schmidt et al et al, , 1989 ) measures patients' satisfaction with 1989) measures patients' satisfaction with treatment. Interactive video-based rater treatment. Interactive video-based rater training on use of the HRSD was conducted training on use of the HRSD was conducted in every hospital, with an average intraclass in every hospital, with an average intraclass coefficient of 0.63 ( coefficient of 0.63 (F F¼2.7, d.f. 2.7, d.f.¼19,418; 19,418 ; P P5 50.001). To assess general information 0.001). To assess general information about patients and the treatment process about patients and the treatment process we modified the German documentation we modified the German documentation system BADO according to the special system BADO according to the special needs of care of in-patients with depression. needs of care of in-patients with depression. The BADO is a standard instrument for The BADO is a standard instrument for quality assurance of psychiatric in-patient quality assurance of psychiatric in-patient care developed by the German Association care developed by the German Association of Psychiatry, Psychotherapy and Neurolof Psychiatry, Psychotherapy and Neurology (DGPPN) (Cording ogy (DGPPN) (Cording et al et al, 1995) . The , 1995) . The modified version consists of three forms: modified version consists of three forms: admission (27 items) course of treatment admission (27 items) course of treatment (7 items) and discharge (29 items). (7 items) and discharge (29 items). 18 years) was included prospectively if they had received in-patient treattively if they had received in-patient treatment for at least 3 days and had ment for at least 3 days and had depressive symptoms meeting one of the depressive symptoms meeting one of the following ICD-10 diagnostic criteria following ICD-10 diagnostic criteria (World Health Organization, 1993) : (World Health Organization, 1993) : depressive episode, bipolar (F31.3-F31.5), depressive episode, bipolar (F31.3-F31.5), depressive episode, unipolar (F32.0-F32.2), depressive episode, unipolar (F32.0-F32.2), depressive episode, recurrent (F33.0-F33.9), depressive episode, recurrent (F33.0-F33.9), dysthymia (F34.1), other chronic depressive dysthymia (F34.1), other chronic depressive disorders (F34.8-F34.9), other affective disdisorders (F34.8-F34.9), other affective disorders (F38-F39) and adjustment disorders orders (F38-F39) and adjustment disorders with depressive symptoms (F43.20-F43.21). with depressive symptoms (F43.20-F43.21). Data were anonymised and sent to the Data were anonymised and sent to the study centre for statistical analysis. Since study centre for statistical analysis. Since the analysis of routine data for quality the analysis of routine data for quality assurance reasons is a legal obligation assurance reasons is a legal obligation according to German healthcare laws, it according to German healthcare laws, it was not necessary to obtain informed conwas not necessary to obtain informed consent from every patient. sent from every patient.
Recruitment procedure Recruitment procedure

Hospital sample Hospital sample
To draw representative conclusions, hospiTo draw representative conclusions, hospitals in different regions, of various type tals in different regions, of various type and size were chosen (Table 1) . Owing to and size were chosen (Table 1) . Owing to differences in average number of addifferences in average number of admissions and for internal organisational missions and for internal organisational reasons, the number of recruited patients reasons, the number of recruited patients differed between hospitals. Half of the differed between hospitals. Half of the patients (50.2%, patients (50.2%, n n¼603) were treated in 603) were treated in state psychiatric hospitals, 28.6% ( state psychiatric hospitals, 28.6% (n n¼344) 344) in general hospitals and 21.2% ( in general hospitals and 21.2% (n n¼255) 255) in university hospitals. About half of the in university hospitals. About half of the sample (48.3%) was treated in north sample (48.3%) was treated in north Germany and about half (51.7%) in south Germany and about half (51.7%) in south Germany. Germany.
Hospitals were invited to cooperate Hospitals were invited to cooperate voluntarily in this study. They were asked voluntarily in this study. They were asked to use the documentation tools to recruit to use the documentation tools to recruit 150 patients. They had the benefit of detailed 150 patients. They had the benefit of detailed comparative feedback ('benchmarking') on comparative feedback ('benchmarking') on their treatment routine. their treatment routine.
Adherence to guidelines Adherence to guidelines
To evaluate adherence to guidelines, we To evaluate adherence to guidelines, we selected some high-priority guideline reselected some high-priority guideline recommendations for treatment of in-patient commendations for treatment of in-patient depression (Table 2 ) and compared these depression (Table 2 ) and compared these with treatment routine as assessed in this with treatment routine as assessed in this study. Since there are a variety of national study. Since there are a variety of national and international guidelines for treatment and international guidelines for treatment of depression, we chose the internationally of depression, we chose the internationally Group differences of categorical data Group differences of categorical data were assessed using the were assessed using the w w 2 2 statistic. Group statistic. Group differences of continuous data were differences of continuous data were examined using analysis of variance examined using analysis of variance (ANOVA). The frequency distribution of (ANOVA Since a considerable number of BDI Since a considerable number of BDI self-ratings were lacking (BDI at self-ratings were lacking (BDI at admission, 15.4%; BDI at discharge, admission, 15.4%; BDI at discharge, 28.6%), we quoted the number of missing 28.6%), we quoted the number of missing 4 6 3 4 6 3 Fig. 1 cases separately (Table 3 ). For the same cases separately (Table 3) . For the same reason we used the HRSD expert ratings reason we used the HRSD expert ratings as the main measure of depression. as the main measure of depression.
RESULTS RESULTS
Patients Patients
Socio-demographic characteristics Socio-demographic characteristics Table 3) .
The levels of self-rated and expert-rated The levels of self-rated and expert-rated depression at admission were correlated depression at admission were correlated (Spearman's (Spearman's r r¼0.43, 0.43, P P5 50.001). The level 0.001). The level of depression at admission differed signifiof depression at admission differed significantly between hospitals, with the mean cantly between hospitals, with the mean HRSD score ranging from 15 to 29 HRSD score ranging from 15 to 29
151.2, d.f.¼9, 9, P P5 50.001). Global 0.001). Global functioning (GAF) was restricted at adfunctioning (GAF) was restricted at admission (mean mission (mean¼45.8; s.d.
45.8; s.d.¼13.5, median 13.5, median ¼48.0; Table 3 ) and also differed between 48.0; Table 3 ) and also differed between hospitals (range 38.3-53.5; hospitals (range 38.3-53.5; w w
Of those included in 0.001). Of those included in the study, 27.3% had fallen ill in the year the study, 27.3% had fallen ill in the year of admission. of admission.
The two most frequent diagnoses were The two most frequent diagnoses were single depressive episode (42.0%) and desingle depressive episode (42.0%) and depressive episode within recurrent depressive pressive episode within recurrent depressive disorder (40.0%), followed by adjustment disorder (40.0%), followed by adjustment disorder (12.2%), depressive episode withdisorder (12.2%), depressive episode within bipolar depressive disorder (4.8%) and in bipolar depressive disorder (4.8%) and dysthymia (1.1%). Psychiatric comorbidity dysthymia (1.1%). Psychiatric comorbidity was reported for 25.1% of patients, with was reported for 25.1% of patients, with drug addiction problems (12.0%), axis II drug addiction problems (12.0%), axis II disorders (6.3%) and anxiety disorders disorders (6.3%) and anxiety disorders (6.0%) as the largest diagnostic groups (6.0%) as the largest diagnostic groups (World Health Organization, 1993) . The (World Health Organization, 1993) . The highest rate of psychiatric comorbidity highest rate of psychiatric comorbidity was found for patients with dysthymia was found for patients with dysthymia (58.3%), followed by patients with (58.3%), followed by patients with recurrent depressive disorder (28.5%). Corecurrent depressive disorder (28.5%). Comorbid physical illness was found in morbid physical illness was found in 33.5% of the total sample, with the highest 33.5% of the total sample, with the highest rate for patients with recurrent depressive rate for patients with recurrent depressive disorder (40.5%), followed by patients disorder (40.5%), followed by patients with bipolar depressive disorder (37.9%). with bipolar depressive disorder (37.9%). Vascular disease (17.7%) was the most Vascular disease (17.7%) was the most frequent reported category, followed by frequent reported category, followed by nutritional and metabolic disorders nutritional and metabolic disorders (10.2%) and orthopaedic diseases (5.6%; (10.2%) and orthopaedic diseases (5.6%; World Health Organization, 1993). World Health Organization, 1993).
Treatment process Treatment process
General treatment strategy General treatment strategy Most patients ( Most patients (n n¼982, 81.7% of the total 982, 81.7% of the total sample) were treated with a combination sample) were treated with a combination of pharmacotherapy and psychotherapy. A of pharmacotherapy and psychotherapy. A combination of pharmacotherapy, psychocombination of pharmacotherapy, psychotherapy and electroconvulsive therapy therapy and electroconvulsive therapy (ECT) was used for 53 patients (4.4% of (ECT) was used for 53 patients (4.4% of the total sample). Of the 782 patients with the total sample). Of the 782 patients with moderate-to-severe depression (HRSD moderate-to-severe depression (HRSD4 417), 17), 95.8% received pharmacotherapy; 91.9% 95.8% received pharmacotherapy; 91.9% of the 160 patients with severe acute of the 160 patients with severe acute stressors and 93.4% of the 76 patients with stressors and 93.4% of the 76 patients with comorbid axis II disorder were treated with comorbid axis II disorder were treated with psychotherapy. psychotherapy.
4 6 4 4 6 4 
Tricyclics and tetracyclics Tricyclics and tetracyclics
Amitriptyline 180^300 mg/day, clomipramine 100^250 mg/day, Amitriptyline 180^300 mg/day, clomipramine 100^250 mg/day, doxepine, imipramine, trimipramine, desipramine 100^300 mg/day, doxepine, imipramine, trimipramine, desipramine 100^300 mg/day, nortriptyline 50^200 mg/day, maprotiline 100^400 mg/day nortriptyline 50^200 mg/day, maprotiline 100^400 mg/day
SSRIs SSRIs
Citalopram, fluoxetine, paroxetine 20^60 mg/day, fluvoxamine Citalopram, fluoxetine, paroxetine 20^60 mg/day, fluvoxamine 50^300 mg/day, sertraline 50^200 mg/day 50^300 mg/day, sertraline 50^200 mg/day 
Prescription of antidepressants Prescription of antidepressants
A total of 93.4% of the sample received A total of 93.4% of the sample received pharmacotherapy during in-patient treatpharmacotherapy during in-patient treatment. Of those, 94.1% were discharged ment. Of those, 94.1% were discharged with antidepressant medication. As shown with antidepressant medication. As shown in Table 4 , the most frequently prescribed in Table 4 , the most frequently prescribed antidepressants were mirtazapine, venlaantidepressants were mirtazapine, venlafaxine and reboxetine (47.8% of patients faxine and reboxetine (47.8% of patients receiving pharmacotherapy), followed by receiving pharmacotherapy), followed by selective serotonin reuptake inhibitors selective serotonin reuptake inhibitors (SSRIs) (30.2%) and tri-and tetracyclics (SSRIs) (30.2%) and tri-and tetracyclics (26.6%). Monoamine oxidase inhibitors (26.6%). Monoamine oxidase inhibitors (MAOIs) were prescribed rarely (2.8%) (MAOIs) were prescribed rarely (2.8%) and not to first-episode patients. For and not to first-episode patients. For 17.5% of patients, more than one anti-17.5% of patients, more than one antidepressant had been prescribed. depressant had been prescribed.
The proportion of patients discharged The proportion of patients discharged with antidepressants ( with antidepressants (w w .f.¼9, 9, P P5 50.001 (Fig. 2) ; SSRIs: 0.001 (Fig. 2) 
Dosage of antidepressants Dosage of antidepressants
Following guideline recommendations Following guideline recommendations (Table 2) , we classified each antidepressant (Table 2) , we classified each antidepressant dosage decision at discharge into either dosage decision at discharge into either adequate, below recommendation or above adequate, below recommendation or above recommendation. In 85% of cases antirecommendation. In 85% of cases antidepressant dosage at discharge was in line depressant dosage at discharge was in line with guideline recommendations. Nearly with guideline recommendations. Nearly every SSRI dosage decision (98.0%) was every SSRI dosage decision (98.0%) was adequate, whereas adherence to guidelines adequate, whereas adherence to guidelines for dosage was lower for antidepressants for dosage was lower for antidepressants such as mirtazapine, venlafaxine and resuch as mirtazapine, venlafaxine and reboxetine (81.0%), tri-/tetracyclics (76.0%) boxetine (81.0%), tri-/tetracyclics (76.0%) and MAOIs (67.0%; Table 4 ). As shown and MAOIs (67.0%; Table 4 ). As shown in Fig. 3 , tri-/tetracyclics tended to be in Fig. 3 
DISCUSSION DISCUSSION
The large sample of patients is comparable The large sample of patients is comparable to other national and international samples to other national and international samples of in-patients with depression in terms of of in-patients with depression in terms of socio-demographic variables and psychosocio-demographic variables and psychopathology at admission (Keller pathology at admission (Keller et al et al, 1986; , 1986; Simon Simon et al et al, 1995; Ackerman , 1995; Ackerman et al et al, 2002; , 2002; Harter Hä rter et al et al, 2004) . The investigation was , 2004). The investigation was carried out in the German in-patient healthcarried out in the German in-patient healthcare system, which is especially well suited care system, which is especially well suited for the study of this question since hospital for the study of this question since hospital admission is free of any direct cost to the admission is free of any direct cost to the patient in Germany. patient in Germany.
Treatment outcome Treatment outcome
The mean treatment outcome was high: the The mean treatment outcome was high: the effect sizes ( effect sizes (d d¼1.5) for BDI expert rating 1.5) for BDI expert rating 4 6 6 4 6 6
Fig. 2 Fig. 2 Proportion of patients taking tri-/tetracyclic antidepressants at discharge. Proportion of patients taking tri-/tetracyclic antidepressants at discharge. and for HRSD self-rating ( and for HRSD self-rating (d d¼2.3) can be 2.3) can be considered large (Cohen, 1988) . Most considered large (Cohen, 1988) . Most patients showed a significant decrease in patients showed a significant decrease in the level of depression during treatment the level of depression during treatment (76.9%) and only two patients deterio-(76.9%) and only two patients deteriorated. The results are comparable with rated. The results are comparable with other evaluation studies of depression treatother evaluation studies of depression treatment in Germany (Hautzinger & deJongment in Germany (Hautzinger & deJongMeyer, 1996; Harter Meyer, 1996; Hä rter et al et al, 2004) . The , 2004) . The decrease in psychopathology and in global decrease in psychopathology and in global functioning during in-patient treatment is functioning during in-patient treatment is not only statistically but also clinically signot only statistically but also clinically significant. The average global functioning at nificant. The average global functioning at discharge (GAF discharge (GAF¼70.2) can be described as 70.2) can be described as having 'some mild symptoms or some diffihaving 'some mild symptoms or some difficulty in social, occupational or school funcculty in social, occupational or school functioning, but generally functioning pretty tioning, but generally functioning pretty well . . .' (American Psychiatric Associawell . . .' (American Psychiatric Association, 1994, p. 759), justifying discharge tion, 1994, p. 759), justifying discharge from in-patient treatment. The mean defrom in-patient treatment. The mean depression score at discharge was on a threshpression score at discharge was on a threshold towards a old towards a non-clinical level of non-clinical level of depression (BDI depression (BDI¼ 11.5, 11.5, HRSD HRSD¼7.1). Many 7.1). Many patients were satisfied with treatment patients were satisfied with treatment (85.9%). Nevertheless, since self-report (85.9%). Nevertheless, since self-report data on patients' satisfaction are missing data on patients' satisfaction are missing for 28.1% of patients, interpretation is for 28.1% of patients, interpretation is limited. There might have been a selection limited. There might have been a selection effect of extraordinarily compliant patients. effect of extraordinarily compliant patients.
Adherence to treatment guidelines Adherence to treatment guidelines
General therapeutic strategies have mainly General therapeutic strategies have mainly been chosen according to guideline recombeen chosen according to guideline recommendations (Table 2 ). Most patients with mendations (Table 2) . Most patients with moderate-to-severe depression received moderate-to-severe depression received pharmacotherapy (95.8%). Psychotherapy pharmacotherapy (95.8%). Psychotherapy can be considered a second core element can be considered a second core element of German in-patient treatment of deof German in-patient treatment of depression. Most patients with a comorbid pression. Most patients with a comorbid axis II disorder (93.4%) or acute stressors axis II disorder (93.4%) or acute stressors (91.9%) were treated with psychotherapy, (91.9%) were treated with psychotherapy, according to guideline recommendations. according to guideline recommendations.
The results also reflect a routine of The results also reflect a routine of antidepressant prescribing which is highly antidepressant prescribing which is highly concordant with guideline recommendaconcordant with guideline recommendations (Table 2) . Only 2.8% of the sample tions (Table 2) . Only 2.8% of the sample and no first-episode patients were preand no first-episode patients were prescribed MAOIs but a large number of scribed MAOIs but a large number of patients received at least one of the patients received at least one of the recommended antidepressants -SSRIs, tri-/ recommended antidepressants -SSRIs, tri-/ tetracyclics or antidepressants such as tetracyclics or antidepressants such as mirtazapine, venlafaxine and reboxetine mirtazapine, venlafaxine and reboxetine (Table 4) . The preference for anti- (Table 4 ). The preference for antidepressants such as mirtazapine, venlafaxdepressants such as mirtazapine, venlafaxine and reboxetine over SSRIs and tri-/ ine and reboxetine over SSRIs and tri-/ tetracylics corresponds to the prescription tetracylics corresponds to the prescription trends in the USA (Ackerman trends in the USA (Ackerman et al et al, 2002) . , 2002). The results concerning dosage of antiThe results concerning dosage of antidepressants give an optimistic picture for depressants give an optimistic picture for the in-patient setting compared with the in-patient setting compared with international and out-patient findings. international and out-patient findings. Only 15% of decisions regarding antiOnly 15% of decisions regarding antidepressant dosage did not satisfactorily depressant dosage did not satisfactorily meet guideline recommendations (Table 2,  meet guideline recommendations (Table 2 , Fig. 3) . Studies from the USA (e.g. Dawson  Fig. 3) . Studies from the USA (e.g. Dawson et al et al, 1999) have reported that up to 50% , 1999) have reported that up to 50% of antidepressant dosages were not in of antidepressant dosages were not in accordance with recommendations. For accordance with recommendations. For out-patient settings, similar rates were out-patient settings, similar rates were reported (44%), with worse treatment outreported (44%), with worse treatment outcome for patients receiving too low a come for patients receiving too low a dosage of antidepressants (Simon dosage of antidepressants (Simon et al et al, , 1995) . 1995).
The high rate of benzodiazepine preThe high rate of benzodiazepine prescribing at discharge (up to 56%) is a point scribing at discharge (up to 56%) is a point for discussion. Combination therapy with for discussion. Combination therapy with benzodiazepines is said to decrease dropbenzodiazepines is said to decrease dropout rates but at the same time there are out rates but at the same time there are concerns about dependence and accident concerns about dependence and accident proneness (Furukawa proneness (Furukawa et al et al, 2002) . Treat-, 2002) . Treatment ment guidelines advise clearly against benzoguidelines advise clearly against benzodiaze diazepines for patients with comorbid drug pines for patients with comorbid drug addiction. In contrast, almost 20% of this addiction. In contrast, almost 20% of this subgroup were still taking benzodiazepines subgroup were still taking benzodiazepines at discharge. The duration of treatment at discharge. The duration of treatment may account for this deviation from guidemay account for this deviation from guideline recommendations. Possibly benzoline recommendations. Possibly benzodiazepine withdrawal had not yet been diazepine withdrawal had not yet been completed and benzodiazepines may have completed and benzodiazepines may have been continued in subsequent out-patient been continued in subsequent out-patient treatment. The fact that only half of the treatment. The fact that only half of the patients with comorbid drug addiction patients with comorbid drug addiction and benzodiazepine prescription at disand benzodiazepine prescription at discharge continued out-patient treatment charge continued out-patient treatment does not support this assumption. does not support this assumption.
The data reflect a restricted routine use The data reflect a restricted routine use of ECT in Germany. This is not in line with of ECT in Germany. This is not in line with guideline recommendations and research guideline recommendations and research findings that showed ECT to be an effective findings that showed ECT to be an effective treatment for patients with severe and psytreatment for patients with severe and psychotic symptoms and those not responding chotic symptoms and those not responding (1998), who (1998) , who showed that the application of ECT in showed that the application of ECT in German hospitals was much more influGerman hospitals was much more influenced by social factors and psychiatrists' enced by social factors and psychiatrists' attitudes than by medical factors. attitudes than by medical factors.
According to guideline recommendaAccording to guideline recommendations (Table 2) , cognitive-behavioural thertions (Table 2) , cognitive-behavioural therapy and interpersonal therapy are the most apy and interpersonal therapy are the most effective specific treatment strategies effective specific treatment strategies for major depressive disorder. While for major depressive disorder. While cognitive-behavioural therapy was the cognitive-behavioural therapy was the most applied therapeutic modality in the most applied therapeutic modality in the present study, interpersonal therapy still present study, interpersonal therapy still seems to be relatively unknown in German seems to be relatively unknown in German psychiatric hospitals. psychiatric hospitals.
Our results emphasise the importance Our results emphasise the importance to outcome of adherence to treatment to outcome of adherence to treatment guidelines. Adherence to guidelines for guidelines. Adherence to guidelines for tricyclic antidepressant dosage, psychotricyclic antidepressant dosage, psychotherapeutic treatment and cognitivetherapeutic treatment and cognitivebehavioural and interpersonal therapy as behavioural and interpersonal therapy as main therapeutic rationales seems to main therapeutic rationales seems to correspond to higher response rates. correspond to higher response rates.
Methodological issues Methodological issues
There was a difference between self-and There was a difference between self-and expert-rated levels of depression in this expert-rated levels of depression in this study, indicating the importance of differstudy, indicating the importance of different methods of assessment in the treatment ent methods of assessment in the treatment of depression. As in out-patient settings, of depression. As in out-patient settings, patients seemed to rate themselves as more patients seemed to rate themselves as more depressed than their therapists did depressed than their therapists did (Schneider (Schneider et al et al, 2004) . Unfortunately , 2004). Unfortunately many self-rating data are missing and hence many self-rating data are missing and hence the validity is restricted. the validity is restricted.
Significant differences between hospiSignificant differences between hospitals were found with respect to patients' tals were found with respect to patients' characteristics at admission ('case mix') as characteristics at admission ('case mix') as well as variables of treatment process and well as variables of treatment process and outcome. This corresponds with a number outcome. This corresponds with a number of other studies (e.g. Harter of other studies (e.g. Hä rter et al et al, 2004) , 2004) and suggests that fair comparisons of treatand suggests that fair comparisons of treatment process and outcome between hospiment process and outcome between hospitals can only be conducted by statistically tals can only be conducted by statistically considering the case mix. considering the case mix.
There are different definitions of adherThere are different definitions of adherence to guidelines in the current literature. ence to guidelines in the current literature. 
, adherence to guidelines for psychiatric adherence to guidelines for psychiatric treatment was assessed using vignettes. treatment was assessed using vignettes. Adherence was defined by an expert panel Adherence was defined by an expert panel based on the three leading Dutch guidebased on the three leading Dutch guidelines, resulting in 73% guideline-adherent lines, resulting in 73% guideline-adherent intentions-to-treat by the participating psyintentions-to-treat by the participating psychiatrists. Fortney chiatrists. Fortney et al et al (2001) found only (2001) found only 29% of an American sample of out-patients 29% of an American sample of out-patients with depression to be treated according to with depression to be treated according to guidelines. In that study adherence to guidelines. In that study adherence to guidelines was defined as antidepressant guidelines was defined as antidepressant medication corresponding with Agency for medication corresponding with Agency for Healthcare Research and Quality guidelines Healthcare Research and Quality guidelines or as a certain number of visits to a speciaor as a certain number of visits to a specialist health provider. Since psychiatric treatlist health provider. Since psychiatric treatment is a complex phenomenon, with many ment is a complex phenomenon, with many variables influencing treatment process and variables influencing treatment process and outcome (Frick outcome (Frick et al et al, 1999; Sitta , 1999; Sitta et al et al, , 2003) , and the specificity of guideline 2003), and the specificity of guideline recommendations is limited, a single score recommendations is limited, a single score for adherence to guidelines seems too refor adherence to guidelines seems too restrictive. 
